A strategic acquisition of the Olympus Laboratory unit

Beckman Coulter Inc, manufacturer of medical test systems, has agreed to acquire the diagnostic systems portion of Olympus Corporation's life sciences business.

‘Beckman Coulter is making this acquisition because the combined businesses are better together – the synergies in terms of products, geographic placement and highly capable people make it very compelling,’ Beckman Coulter explained. ‘We will create a world-leading company in clinical diagnostics with special strength in chemistry and automated laboratory systems. Once the acquisition closes, we expect to have global market share that places us near the top of the chemistry segment.
‘This is a very strategic acquisition — Olympus’ chemistry systems fill some important gaps in our product line, providing outstanding systems for customers in both the ultra-high throughput and the low-volume segments.
‘We’ve also been very successful at placing our immunoassay systems with our chemistry customers. The access to Olympus’ installed base should give us more opportunities to continue the growth of our immunoassay business.
‘We think that the combination of Olympus’ ultra-high throughput chemistry systems with our UniCel DxI 800 — the highest throughput immuno-assay analyser available today — will be very attractive to customers around the world, especially in Europe and Japan.
‘Our automation product lines are also complementary. We’re a world leader in connected, total lab automation. Olympus is the leader in pre-analytical automation – we’ll be able to offer customers who need automation more choices and better solutions.’


Read all latest stories

Related articles


Sponsored • 100th DxA Automation System installed

Automation reimagines laboratory diagnostics service

San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman…


Sponsored • Infection management

New sepsis marker speeds up detection and therapy

Sepsis is the cause of one in five deaths worldwide, killing nearly 11 million people each year, many of them children. It is also a major cause of disability, affecting millions more. To combat the…


Interview • Urinalysis for Covid-19 diagnostics

Automation to relieve pandemic pressure from laboratories

To provide a solution for the challenges of the coronavirus pandemic, Beckman Coulter recently launched the DxU Iris, a urinalysis solution which aims to improve lab workflows.

Related products

Subscribe to Newsletter